Vesalius3D vs. Seegnal

Vesalius3D is a cutting-edge software application that facilitates remarkable 3D visualization and examination of unique anatomical structures tailored to individual patients. This innovative tool allows users to examine fine details within a patient's anatomy that might be missed when using only conventional 2D imaging techniques. Featuring an intuitive interface, the software makes it easy to navigate through complex anatomical layers, ensuring a smooth user experience. Significantly, Vesalius3D is compatible with common medical imaging technologies such as CT, MRI, and Ultrasound, which means there is no requirement for specialized imaging to utilize its capabilities. It also includes presets that cater to the most commonly encountered types of tissue, enhancing the user experience further. Moreover, the software provides pre-set visualizations, enabling users to quickly access results without needing to make extensive manual adjustments, which is particularly beneficial for frequently examined tissues. In addition to visualization, Vesalius3D encompasses a variety of measurement tools that facilitate both 2D measurements—like distances, angles, and contour areas—and advanced 3D quantification to accurately evaluate shapes, contours, and spatial relationships. This extensive range of features greatly enhances the ability of healthcare professionals to efficiently gain deeper insights into patient anatomy. Consequently, Vesalius3D not only improves visualization but also streamlines the overall workflow for medical practitioners.

An intuitive real-time user interface created for use at the point of care significantly improves the prevention of Drug-Related Problems (DRPs) tailored to individual patients. DRPs rank as the fourth leading cause of mortality in the United States, resulting in around 150,000 deaths annually and comprising 6-10% of all hospital admissions. Moreover, patients who are prescribed five or more medications face over a 20% likelihood of experiencing serious DRPs, which in turn contribute to billions of dollars in avoidable healthcare expenses. Each month, nearly 4.5 million individuals in the U.S. visit emergency rooms due to complications arising from DRPs. The platform features the most extensive data integration available, offering 50% more unique information and the ability to synchronize data from multiple sources. By leveraging AI and machine learning, it delivers real-time insights customized to each patient, incorporating factors such as lab results, estimated glomerular filtration rate (eGFR), genetic profiles, dietary habits, and usage of over-the-counter drugs. With a remarkable accuracy rate of 98% for both specificity and sensitivity, it significantly reduces alert fatigue by generating only 6% of the alerts typically issued by conventional systems. Additionally, the patented visualization technology employed at the point of care facilitates the swift detection, prioritization, and resolution of issues within a rapid timeframe of just 5 to 10 seconds, ensuring that patient care is both timely and effective. This cutting-edge methodology not only reduces the risks linked to DRPs but also promotes overall healthcare efficiency, ultimately leading to improved patient outcomes and satisfaction.